Clinical Trial Update: Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy, safety, and tolerability of an intramuscular aripiprazole formulation (OPC-14597) as maintenance treatment in Bipolar I Disord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2018-08-24